Chromocell Therapeutics Corporation (CHRO) stock surged +97.92%, trading at $1.90 on AMEX, up from the previous close of $0.96. The stock opened at $1.09, fluctuating between $1.00 and $2.44 in the recent session.
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Employees | 4 |
Beta | 0 |
Sales or Revenue | N/A |
5Y Sales Change% | -1% |
Fiscal Year Ends | N/A |
Sector | Healthcare |
Industry | Biotechnology |
Chromocell Therapeutics Corporation (AMEX: CHRO) stock price is $1.90 in the last trading session. During the trading session, CHRO stock reached the peak price of $2.44 while $1.00 was the lowest point it dropped to. The percentage change in CHRO stock occurred in the recent session was 97.92% while the dollar amount for the price change in CHRO stock was $0.94.
The AMEX listed CHRO is part of Biotechnology industry that operates in the broader Healthcare sector. Chromocell Therapeutics Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
CHRO's closing price is 322.22% higher than its 52-week low of $0.45 where as its distance from 52-week high of $6.00 is -68.33%.
Number of CHRO employees currently stands at 4.
Official Website of CHRO is: https://chromocell.com
CHRO could be contacted at phone 732 514 2636 and can also be accessed through its website. CHRO operates from 4400 Route 9 South, Freehold, NJ 07728, United States.
CHRO stock volume for the day was 14.11M shares. The average number of CHRO shares traded daily for last 3 months was 122.34K.
The market value of CHRO currently stands at $11.45M with its latest stock price at $1.90 and 6.03M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com